The role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the management of portal hypertension

Journal of Clinical Gastroenterology

Volumn 41, Issue SUPPL. 3, 2007, Pages

  Colombato, Luis ^a  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

Author keywords

Bleeding; Encephalopathy; Esophagogastric varices; Portosystemic shunt; TIPS; Transjugular

Indexed keywords

ASCITES; BLOOD VESSEL INJURY; CONFERENCE PAPER; ESOPHAGUS VARICES BLEEDING; HEART ARREST; HEMOBILIA; HEMOLYTIC ANEMIA; HEMOPERITONEUM; HEPATIC ENCEPHALOPATHY; HEPATIC VEIN; HEPATORENAL SYNDROME; HUMAN; LIVER CIRRHOSIS; LIVER ISCHEMIA; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROSTHESIS FAILURE; SEPSIS;

ASCITES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEPATIC ENCEPHALOPATHY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; PATIENT SELECTION; PORTAL PRESSURE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PULMONARY EDEMA; RECURRENCE; TREATMENT OUTCOME;

EID: 35848957879     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318157e500     Document Type: Conference Paper

References (53)

1. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunt. Gastroenterology. 1997;112:889-898.
2. Boyer TD. Transjugular intra-hepatic portosystemic shunt: current status. Gastroenterology. 2003;124:1700-1710.
3. Conn H. Transjugular intrahepatic porto-systemic shunts: state of the art. Hepatology. 1993;17:148-158.
4. Hassoun Z, Pomier-Layragues G. Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy. Am J Gastroenterol. 2001;96:1205-1209.
5. Garcia-Tsao G. Transjugular intra-hepatic porto-systemic shunt for the management of refractory ascites. Nat Clin Prac Gastroenterol Hepatol. 2006;3:380-389.
6. Colombato LA, Spahr L, Martinet JP, et al. Hemodynamic adaptation two months after TIPS in cirrhotic patients. Gut. 1996;39:600-604.
7. Rösch J, Hanafe WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology. 1969;92:1112-1114.
8. Rössle M, Richter GM, Nöldle G, et al. Performance of an intrahepatic portacaval shunt (PCS) using a catheter technique. A case report [abstract]. Hepatology. 1988;8:1348.
9. Cello JP, Grendel JH, Crass RA, et al. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med. 1984;311:1589-1594.
10. Grace ND. The side to side portocaval shunt revisited. N Engl J Med. 1994;330:208-209.
11. Burroughs AK, McCormick PA. TIPS: have the initial expectations been fulfilled? In: Bosch J, Groszmann RJ, eds. Portal Hypertension. Pathophysiology and Treatment. London: Blackwell; 1994:164-179.
12. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites and spontaneous bacterial peritonitis. Gastroenterology. 2001;120:726-748.
13. Sanyal AJ, Freedman AM, Purdum PP, et al. The hepatologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology. 1996;23:32-39.
14. Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology. 1996;111:138-146.
15. Boyer TD, Haskal ZJ. AASLD Practice Guideline. The role of transjugular intra-hepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:1-15.
16. Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using PTFE coated stents for TIPS. Results of a randomized study. Gastroenterology. 2004;126:469-475.
17. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno Consensus Conference on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;42:167-176.
18. Bilodeau M, Rioux L, Willems B, et al. Transjugular intrahepatic portocaval stent shunt as a rescue treatment for life threatening variceal bleeding in a cirrhotic patient with severe liver failure. Am J Gastroenterol. 1992;87:369-371.
19. Monescillo A, Martinez-Lagares F, Ruiz-del-Árbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40:793-801.
20. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846-852.
21. Bosch J, Abraldes JG, Groszmann RJ. Current management of portal hypertension. J Hepatol. 2003;38:S54-S58.
22. Vangeli M, Patch D, Burroughs AK. Salvage TIPS for uncontrolled variceal bleeding. J Hepatol. 2003;37:703-704.
23. Sanyal AJ, Freedman AM, Shiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology. 1994;20:46-55.
24. Urata J, Yamashita Y, Tsuchigame T, et al. The effect of transjugular portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol. 1998;13:977-979.
25. Burak KW, Lee SS, Beck PL. Portal hypertensive gastropathy and gastric vascular ectasia (GAVE) syndrome. Gut. 2001;49:866-872.
26. Kamath PS, Lacerda M, Ahlquist DA, et al. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology. 2000;118:905-911.
27. Tripathy D, Jalan R. Transjugular intrahepatic portosystemic stent in the management of ectopic and gastric varices. Eur J Gastroenterol Hepatol. 2006;11:1155-1160.
28. Mihas AA, Sanyal AJ. Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology. 2004;127:621-629.
29. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic view. Hepatology. 1995;22:332-353.
30. Escorsell AM, Bañares R, Garcia-Pagan JC, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis. A randomized control trial. Hepatology. 2002;35:385-392.
31. Papatheodoridis GV, Goulis J, Leandro G, et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology. 1999;30:612-622.
32. Rosemurgy AS, Bloomston M, Clark WC, et al. H-graft portocaval shunts vs. TIPS: ten years follow-up of a randomized trial with comparison to predicted survival. Ann Surg. 2005;241:238-246.
33. Henderson JM, Boyer TD, Kutner MH, et al. Distal splenorenal shunt vs. transjugular intrahepatic portal systemic shunt for variceal bleeding: a randomized trial. Gastroenterology. 2006;130:1643-1657.
34. Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunt versus repeated paracentesis plus intravenous albumin for refractory ascites in cirrhosis. A multicenter randomized comparative study. Gastroenterology. 2002;123:1839-1847.
35. Campbell MS, Brensinger C, Sanyal A, et al. Quality of life in refractory ascites: the changes and impact following transjugular intrahepatic portosystemic shunt versus medical therapy. Hepatology. 2005;42:635-640.
36. Wong F. The use of TIPS in chronic liver disease. Ann Hepatol. 2006;5:5-15.
37. Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004;40:629-635.
38. Albillos A, Bañares R, Gonzalez M, et al. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol. 2005;43:990-996.
39. Freedman AM, Sanyal AJ, Tisnado J, et al. Complications of transjugular intrahepatic porto-systemic shunt: a comprehensive review. Radiographics. 1993;13:1185-1210.
40. Bouza E, Muñoz P, Rodriguez C, et al. Endotipsitis, an emerging prosthetic-related infection in patients with portal hypertension. Diagn Microbiol Infect Dis. 2004;49:77-82.
41. Lafortune M, Martinet JP, Denys A, et al. Short and long term hemodynamic effects of TIPS: a Doppler/manometric correlation study. Am J Roentgenol Radium Ther Nucl Med. 1995;164:997-1002.
42. Barrio J, Ripoll C, Bañares R, et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Eur J Radiol. 2005;55:120-124.
43. Angermayr B, Cejna M, Koenig F, et al. Vienna TIPS Study Group. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stent grafts versus bare stents. Hepatology. 2003;38:1043-1050.
44. Rossi P, Salvatori F, Fanelli F, et al. Polytetrafluorethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology. 2004;231:820-830.
45. Riggio O, Masini A, Efrati C. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intra-hepatic portosystemic shunt: a randomized controlled study. J Hepatol. 2005;43:674-679.
46. Hauenstein KH, Haag K, Ochs A, et al. Reducing stent for TIPS-induced refractory hepatic encephalopathy and liver failure. Radiology. 1994;194:175-179.
47. Maleux G, Verslype C, Heye S, et al. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent grafts. AJR. 2007;188:659-664.
48. Azoulay D, Castaing D, Dennison A, et al. Transjugular intrahepatic porto-systemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective atudy. Hepatology. 1994;19:129-132.
49. Colombato LA, Martinet JP, Dufresne MP, et al. Acute hemodynamic effect of TIPS on cirrhotic patients [abstract]. Hepatology. 1994;19:531.
50. Jalan R, Elton RA, Redhead DN, et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol. 1995;23:123-128.
51. Chalasani N, Clark WS, Martin LG, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic porto-systemic shunting. Gastroenterology. 2000;118:138-144.
52. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunt. Hepatology. 2000;31:864-871.
53. Ring-Larsen H, Hesse B, Stigsby B. Effect of portal-systemic anastomosis on renal hemodynamics in cirrhosis. Gut. 1976;17:856-860.